Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
|
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
欧盟地平线“2020”; 美国国家卫生研究院; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
    Maya Arvidsson Rådestig
    Ingmar Skoog
    Tobias Skillbäck
    Henrik Zetterberg
    Jürgen Kern
    Anna Zettergren
    Ulf Andreasson
    Hanna Wetterberg
    Silke Kern
    Kaj Blennow
    Alzheimer's Research & Therapy, 15
  • [2] Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia
    Mattsson, Niklas
    Ruetschi, Ulla
    Pijnenburg, Yolande A. L.
    Blankenstein, Marinus A.
    Podust, Vladimir N.
    Li, Susann
    Fagerberg, Inger
    Rosengren, Lars
    Blennow, Kaj
    Zetterberg, Henrik
    MOLECULAR MEDICINE REPORTS, 2008, 1 (05) : 757 - 761
  • [3] Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
    Antonell, Anna
    Tort-Merino, Adria
    Rios, Jose
    Balasa, Mircea
    Borrego-Ecija, Sergi
    Auge, Josep M.
    Munoz-Garcia, Cristina
    Bosch, Beatriz
    Falgas, Neus
    Rami, Lorena
    Ramos-Campoy, Oscar
    Blennow, Kaj
    Zetterberg, Henrik
    Molinuevo, Jose L.
    Llado, Albert
    Sanchez-Valle, Raquel
    ALZHEIMERS & DEMENTIA, 2020, 16 (02) : 262 - 272
  • [4] Cerebrospinal fluid biomarkers in frontotemporal lobar degeneration
    Baldeiras, I.
    Santana, I.
    Santiago, B.
    Correia, H.
    Ribeiro, M. H.
    Lemos, R.
    Duro, D.
    Oliveira, C.
    JOURNAL OF NEUROLOGY, 2011, 258 : 183 - 183
  • [5] Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration
    Fanara, Patrizia
    Wong, Po-Yin A.
    Husted, Kristofor H.
    Liu, Shanshan
    Liu, Victoria M.
    Kohlstaedt, Lori A.
    Riiff, Timothy
    Protasio, Joan C.
    Boban, Drina
    Killion, Salena
    Killian, Maudi
    Epling, Lorrie
    Sinclair, Elisabeth
    Peterson, Julia
    Price, Richard W.
    Cabin, Deborah E.
    Nussbaum, Robert L.
    Bruehmann, Joerg
    Brandt, Roland
    Christine, Chadwick W.
    Aminoff, Michael J.
    Hellerstein, Marc K.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (09): : 3159 - 3169
  • [6] Population-Based Evaluation of Total Protein in Cerebrospinal Fluid
    Fautsch, Kalli J.
    Block, Darci R.
    Graff-Radford, Jonathan
    Wang, Feng
    Craver, Emily C.
    Hodge, David O.
    Cutsforth-Gregory, Jeremy K.
    Kilgore, Khin P.
    Petersen, Ronald C.
    Knopman, David S.
    Flanagan, Eoin
    Toledano, Michel
    Mielke, Michelle M.
    Bhatti, M. Tariq
    Chen, John J.
    MAYO CLINIC PROCEEDINGS, 2023, 98 (02) : 239 - 251
  • [7] Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
    Bloniecki, Victor
    Zetterberg, Henrik
    Aarsland, Dag
    Vannini, Patrizia
    Kvartsberg, Hlin
    Winblad, Bengt
    Blennow, Kaj
    Freund-Levi, Yvonne
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [8] Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
    Victor Bloniecki
    Henrik Zetterberg
    Dag Aarsland
    Patrizia Vannini
    Hlin Kvartsberg
    Bengt Winblad
    Kaj Blennow
    Yvonne Freund-Levi
    Alzheimer's Research & Therapy, 12
  • [9] Cerebrospinal fluid synaptic biomarkers in AT(N)-based subgroups of Lewy body disease
    Barba, L.
    Abur-Rumeileh, S.
    Halbgebauer, S.
    Bellomo, G.
    Paoletti, F. Paolini
    Gaetani, L.
    Massa, F.
    Oeckl, P.
    Steinacker, P.
    Parnetti, L.
    Otto, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 168 - 168
  • [10] No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
    Madlyne Becker
    Clotilde Latarche
    Emilie Roman
    Marc Debouverie
    Catherine Malaplate-Armand
    Francis Guillemin
    BMC Neurology, 15